Suven Life Sciences to invest in research & development

Details

Category: USFDA Approvals

Suven Life Sciences Ltd to invest around Rs.2400 million in research & development. The funds required will be met through issue of equity shares, GDR and ADR and foreign currency convertible bonds. It may be noted, it recently has got USFDA approval for its Suryapet facility at Nalagonda district in Andhra Pradesh. Its Pashamylaram unit has already received that approval in late 2007.

• < Prev
• Next >